camptothecin has been researched along with d-alpha tocopherol in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 14 (66.67) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Baltas, M; Bedos-Belval, F; Delomenède, M; Duran, H; Gornitzka, H; Negre-Salvayre, A; Rakotondramanana, DL; Rasoanaivo, P | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Anderson, K; Atkinson, J; Bandyopadhyay, A; Gilbert, BE; Kline, K; Knight, V; Lawson, KA; Sanders, BG; Simmons-Menchaca, M; Snyder, RM; Sun, LZ | 1 |
| Elbayoumi, TA; Mu, L; Torchilin, VP | 1 |
| Gao, Y; Li, LB; Zhai, G | 1 |
| Sawant, RM; Sawant, RR; Torchilin, VP | 1 |
| Li, LB; Wang, J; Wang, R | 1 |
| Drozda, R; Grzegorczyk, K; Kontek, R; Sliwiński, M | 1 |
| Anderson, K; Burris, HA; Jones, S; Marier, JF; Pheng, L; Porubek, D; Trinh, MM; Warner, S | 1 |
| Ding, LY; Guo, M; Liu, YQ; Lu, Y; Ron, WT; Song, FF; Wang, Y; Yu, SQ | 1 |
| Amano, T; Amatya, R; Black, KL; Hanson, CJ; Lee, BS; Pantoja, JL; Wang, HQ; Yen, A; Yoon, CW; Yu, JS | 1 |
| Jakubczak, M; Kontek, R; Matlawska-Wasowska, K | 1 |
| Bhori, M; Marar, T; Singh, K | 1 |
| Hou, J; Lu, Y; Qi, SS; Rong, WT; Wang, DF; Xiao, Q; Xu, Q; You, J; Yu, SQ; Zhang, J | 1 |
| Adamo, RF; Alferiev, IS; Brodeur, GM; Chorny, M; Croucher, JL; Fishbein, I; Iyer, R; Kolla, V; Levy, RJ; Mangino, JL; Zhang, K | 1 |
| Bhori, M; Chilakapati, MK; Marar, T; Singh, K | 1 |
| Ahmad, I; Eltahan, AS; Kaleem, QM; Li, C; Liang, XJ; Mozhi, A; Tuguntaev, RG; Wang, C; Yang, R | 1 |
| Brüggemann, O; Hassel, AW; Mardare, CC; Quiñones, JP | 1 |
| Fan, G; Jia, S; Lin, K; Shi, J; Yu, S; Yuan, J; Zhang, Y; Zhou, Q | 1 |
| Chen, M; Chen, Z; Li, X; Wang, T; Xie, S; Zhang, Z | 1 |
| Prud'homme, RK; Sinko, PJ; Wilson, BK | 1 |
1 trial(s) available for camptothecin and d-alpha tocopherol
| Article | Year |
|---|---|
Pharmacokinetics of SN2310, an injectable emulsion that incorporates a new derivative of SN-38 in patients with advanced solid tumors.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Camptothecin; Chemistry, Pharmaceutical; Emulsions; Female; Half-Life; Humans; Infusions, Intravenous; Irinotecan; Male; Maximum Tolerated Dose; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neutropenia; Succinates; Technology, Pharmaceutical; Vitamin E | 2011 |
20 other study(ies) available for camptothecin and d-alpha tocopherol
| Article | Year |
|---|---|
Synthesis of ferulic ester dimers, functionalisation and biological evaluation as potential antiatherogenic and antiplasmodial agents.
Topics: Animals; Antioxidants; Atherosclerosis; Cell Survival; Coumaric Acids; Dimerization; Endothelium, Vascular; Esters; Humans; Leukemia P388; Lipoproteins, LDL; Mice; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Thiobarbituric Acid Reactive Substances | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.
Topics: Aerosols; alpha-Tocopherol; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Female; Lymphatic Metastasis; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Vitamin E | 2004 |
Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Stability; Humans; Micelles; Nanostructures; Particle Size; Polyethylene Glycols; Solubility; Vitamin E | 2005 |
Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cell Survival; Colorimetry; Drug Screening Assays, Antitumor; Female; Humans; Micelles; Molecular Structure; Poloxamer; Polyethylene Glycols; Solubility; Vitamin E | 2008 |
Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Stability; Hydrolysis; Mice; Micelles; Nucleosomes; Paclitaxel; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Solubility; Technology, Pharmaceutical; Time Factors; Vitamin E | 2008 |
Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer.
Topics: Camptothecin; Cell Line, Tumor; Drug Carriers; Humans; Micelles; Nanoparticles; Polyethylene Glycols; Polymers; Vitamin E | 2009 |
Genotoxicity of irinotecan and its modulation by vitamins A, C and E in human lymphocytes from healthy individuals and cancer patients.
Topics: Adult; Antineoplastic Agents, Phytogenic; Ascorbic Acid; Camptothecin; Comet Assay; DNA Damage; DNA Repair; Female; Humans; Irinotecan; Lymphocytes; Male; Middle Aged; Mutagens; Vitamin A; Vitamin E | 2010 |
Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Emulsions; Humans; Irinotecan; Lactic Acid; Materials Testing; Nanocapsules; Nanoparticles; Neoplasms, Experimental; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2012 |
Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma.
Topics: alpha-Tocopherol; Animals; Antioxidants; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Glioblastoma; Mice; Nanocapsules; Prodrugs; Reactive Oxygen Species; Treatment Outcome | 2013 |
The antioxidants, vitamin A and E but not vitamin C and melatonin enhance the proapoptotic effects of irinotecan in cancer cells in vitro.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Ascorbic Acid; Camptothecin; Cell Line, Tumor; Coloring Agents; Flow Cytometry; HT29 Cells; Humans; In Situ Nick-End Labeling; Irinotecan; Melatonin; Necrosis; Vitamin A; Vitamin E | 2014 |
α-Tocopherol mediated amelioration of camptothecin-induced free radical damage to avert cardiotoxicities.
Topics: Alanine Transaminase; Alkaline Phosphatase; alpha-Tocopherol; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Aspartate Aminotransferases; Camptothecin; Cardiotoxicity; Catalase; Free Radicals; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Lipid Peroxidation; Male; Myocardium; Rats, Wistar; Superoxide Dismutase; Topoisomerase I Inhibitors | 2015 |
TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Irinotecan; Lactic Acid; Mitochondria; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vitamin E | 2015 |
Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.
Topics: alpha-Tocopherol; Animals; Camptothecin; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Humans; Irinotecan; Mice, Nude; Nanoparticles; Neuroblastoma; Particle Size; Prodrugs; Treatment Outcome | 2015 |
Exploring the effect of vitamin E in cancer chemotherapy-A biochemical and biophysical insight.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Biophysical Phenomena; Camptothecin; DNA Fragmentation; Drug Interactions; HeLa Cells; Humans; Spectrum Analysis, Raman; Vitamin E | 2018 |
Nrp-1 receptor targeting peptide-functionalized TPGS micellar nanosystems to deliver 10-hydroxycampothecin for enhanced cancer chemotherapy.
Topics: A549 Cells; Apoptosis; Camptothecin; Cell Nucleus; DNA Topoisomerases, Type I; Drug Carriers; Drug Synergism; Hep G2 Cells; Humans; Inhibitory Concentration 50; MCF-7 Cells; Micelles; Mitochondria; Nanoparticles; Neoplasms; Neuropilin-1; Peptides; Polymers; Reactive Oxygen Species; Topoisomerase I Inhibitors; Vitamin E | 2018 |
Testosterone- and vitamin-grafted cellulose ethers for sustained release of camptothecin.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cellulose; Delayed-Action Preparations; Drug Liberation; Ergocalciferols; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Nanostructures; Particle Size; Testosterone; Vitamin E; Vitamins | 2019 |
Specific Modification with TPGS and Drug Loading of Cyclodextrin Polyrotaxanes and the Enhanced Antitumor Activity Study in Vitro and in Vivo.
Topics: Animals; Anticarcinogenic Agents; Camptothecin; Cell Line, Tumor; Cellulose; Cyclodextrins; Drug Delivery Systems; Humans; Mice; Nanoparticles; Neoplasms; Rotaxanes; Vitamin E; Xenograft Model Antitumor Assays | 2019 |
Synergistic antitumor efficacy of hybrid micelles with mitochondrial targeting and stimuli-responsive drug release behavior.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Drug Synergism; Humans; Hyaluronic Acid; Mice; Micelles; Mitochondria; Neoplasms; Polyesters; Reactive Oxygen Species; Survival Rate | 2019 |
Encapsulation and Controlled Release of a Camptothecin Prodrug from Nanocarriers and Microgels: Tuning Release Rate with Nanocarrier Excipient Composition.
Topics: alpha-Tocopherol; Camptothecin; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Excipients; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Lactates; Microgels; Nanoparticles; Polyesters; Polyethylene Glycols; Prodrugs; Solubility | 2021 |